Lameditech (462510) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Lameditech is dated 2024-06-17; the most recent is 2025-09-19. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2025-09-19 | BUY | 주식매수청구권 행사 | 장창욱 Changwook Jang | CFO/Vice President | 32.0K | ₩7,020 | -27.5% | ₩225M ($156K) |
| 2025-06-20 | BUY | 기타 | 강민정 Minjeong Kang | moving | 2.5K | ₩8,230 | -38.1% | ₩21M ($14K) |
| 2025-03-21 | BUY | 주식매수청구권 행사 | 정봉균 Jeong Bong-gyun | Managing Director | 55.2K | ₩7,730 | -34.1% | ₩427M ($296K) |
| 2025-03-21 | BUY | 주식매수청구권 행사 | 장창욱 Changwook Jang | CFO/Vice President | 15.0K | ₩7,730 | -34.1% | ₩116M ($81K) |
| 2025-03-21 | BUY | 주식매수청구권 행사 | 임채승 Lim Chae-seung | Other non-executive directors | 50.0K | ₩7,730 | -34.1% | ₩387M ($268K) |
| 2024-06-17 | BUY | 신규보고 | 박병철 Park Byeong-cheol | Managing Director | 176.7K | ₩24,550 | -79.3% | ₩4.3B ($3.0M) |
| 2024-06-17 | BUY | 신규보고 | 임채승 Lim Chae-seung | Other non-executive directors | 19.3K | ₩24,550 | -79.3% | ₩473M ($328K) |
| 2024-06-17 | BUY | 신규보고 | 최종석 Choi Jong-seok | CEO | 2.2M | ₩24,550 | -79.3% | ₩53.6B ($37.3M) |
| 2024-06-17 | BUY | 신규보고 | 백광열 Baek Gwang-yeol | moving | 1.5K | ₩24,550 | -79.3% | ₩37M ($26K) |
| 2024-06-17 | BUY | 신규보고 | 장창욱 Changwook Jang | CFO/Executive Director | 132.1K | ₩24,550 | -79.3% | ₩3.2B ($2.3M) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Lameditech. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.